<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Featured &#8211; American Thyroid Association</title>
	<atom:link href="https://www.thyroid.org/category/featured/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.thyroid.org</link>
	<description>Thyroid Cancer, Hyperthyroid, Hypothyroid, Thyroiditis, Thyroid Clinical Trials, Tyroid Patient Health Information</description>
	<lastBuildDate>Mon, 16 Mar 2026 12:55:21 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=5.4.19</generator>
	<item>
		<title>2025 ATA Differentiated Thyroid Cancer Guidelines: Completion Thyroidectomy- Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-march-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 16 Mar 2026 12:55:21 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=78011</guid>

					<description><![CDATA[<p>A significant change in the 2025 thyroid cancer guidelines is an increase in the recommendation of lobectomy. Prior guidelines indicate that completion thyroidectomy is considered in up to 20% of patients with a lobectomy and cancer >2 and ≤4 cm. This paper summarizes the changes in recommendations for completion thyroidectomy in the 2025 ATA differentiated thyroid cancer guidelines. </p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-march-2026/">2025 ATA Differentiated Thyroid Cancer Guidelines: Completion Thyroidectomy- Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>A significant change in the 2025 thyroid cancer guidelines is an increase in the recommendation of lobectomy. Prior guidelines indicate that completion thyroidectomy is considered in up to 20% of patients with a lobectomy and cancer >2 and ≤4 cm. This paper summarizes the changes in recommendations for completion thyroidectomy in the 2025 ATA differentiated thyroid cancer guidelines.  <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/march-2026/vol-19-issue-2-p-9-10/"><strong> Read More&#8230;</strong></a></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-march-2026/">2025 ATA Differentiated Thyroid Cancer Guidelines: Completion Thyroidectomy- Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>New Thyroid Stimulating Podcast: Adding to the Toolbox: Thyroid Artery Embolization</title>
		<link>https://www.thyroid.org/ata-medscape-collaboration-02-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Wed, 25 Feb 2026 23:28:20 +0000</pubDate>
				<category><![CDATA[Corporate News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77940</guid>

					<description><![CDATA[<p>Who is eligible for TAE and who is not? How does it compare with surgery, radioactive iodine, or thermal ablation? What should we be telling our patients about expectations, safety, and follow-up after TAE procedures?</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/ata-medscape-collaboration-02-2026/">New Thyroid Stimulating Podcast: Adding to the Toolbox: Thyroid Artery Embolization</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Drs Kaniksha Desai and Juan Camacho dive into a newer topic that many endocrinologists and primary care clinicians are starting to hear more about, ask more questions about, and encounter more frequently, which is thyroid artery embolization, or TAE. <strong><a href="https://www.medscape.com/viewarticle/1003208" target="_blank" rel="noopener noreferrer">Listen Now</a></strong>.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/ata-medscape-collaboration-02-2026/">New Thyroid Stimulating Podcast: Adding to the Toolbox: Thyroid Artery Embolization</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Thyroid®: Artificial Intelligence Applications in Thyroid Cancer Diagnosis: 2026 Update</title>
		<link>https://www.thyroid.org/thyroid-highlighted-article-jan-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Thu, 19 Feb 2026 23:19:59 +0000</pubDate>
				<category><![CDATA[Corporate News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Thyroid Journal]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77817</guid>

					<description><![CDATA[<p>All Thyroid® articles are  free to read through the end of March as we transition to the new Sage Journals.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/thyroid-highlighted-article-jan-2026/">Thyroid®: Artificial Intelligence Applications in Thyroid Cancer Diagnosis: 2026 Update</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a class="ga-track-click" ga-event-category="CTOpenAccess" target="_blank" rel="noopener noreferrer" href="https://journals.sagepub.com/doi/10.1177/10507256251412316"><strong>Artificial Intelligence Applications in Thyroid Cancer Diagnosis: 2026 Update</strong></a><br />
Johnson Thomas and Franklin N. Tessler</p>
<p><strong>All Thyroid<sup>®</sup> articles are <a href="https://journals.sagepub.com/home/THY" target="_blank" rel="noopener noreferrer">free to read</a> through the end of March as we transition to the new Sage Journals.</strong></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/thyroid-highlighted-article-jan-2026/">Thyroid®: Artificial Intelligence Applications in Thyroid Cancer Diagnosis: 2026 Update</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Medscape &#038; ATA Podcast Collaboration Presents Thyroid Stimulating Podcast: Nanosecond Pulsed Field Ablation: Expanding the Toolbox</title>
		<link>https://www.thyroid.org/ata-medscape-collaboration-01-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Thu, 19 Feb 2026 23:06:07 +0000</pubDate>
				<category><![CDATA[Corporate News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77815</guid>

					<description><![CDATA[<p>This podcast was created in partnership with the American Thyroid Association to discuss up-to-date diagnosis and management of a wide array of thyroid diseases.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/ata-medscape-collaboration-01-2026/">Medscape &#038; ATA Podcast Collaboration Presents Thyroid Stimulating Podcast: Nanosecond Pulsed Field Ablation: Expanding the Toolbox</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Drs. Kaniksha Desai and Ralph Tufano dive into one of the most exciting and rapidly evolving innovations in thyroid nodule management, nanosecond pulsed field ablation technique, also known as nsPFA. This podcast is created in partnership with the American Thyroid Association® and Medscape to discuss up-to-date diagnosis and management of a wide array of thyroid diseases. <strong><a href="https://www.medscape.com/viewarticle/1003164?form=fpf" target="_blank" rel="noopener noreferrer">Listen Now</a></strong>.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/ata-medscape-collaboration-01-2026/">Medscape &#038; ATA Podcast Collaboration Presents Thyroid Stimulating Podcast: Nanosecond Pulsed Field Ablation: Expanding the Toolbox</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Development of a model to predict who will need to take a thyroid hormone pill after partial removal of the thyroid gland &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-february-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Wed, 18 Feb 2026 00:52:19 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<category><![CDATA[Thyroid Surgery]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77799</guid>

					<description><![CDATA[<p>The study authors reviewed the medical records for all patients who underwent partial thyroidectomy at their institution between 2013 and 2020. They identified 425 patients who met study criteria. The authors then identified which of these patients were prescribed levothyroxine after surgery.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-february-2026/">Development of a model to predict who will need to take a thyroid hormone pill after partial removal of the thyroid gland &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>When all of the thyroid is removed by surgery, patients will require a thyroid pill after surgery. When only part of the thyroid gland is removed during surgery (partial thyroidectomy or thyroid lobectomy), the thyroid tissue left behind might produce enough thyroid hormone to meet the body’s needs. The goal of this study was to develop a model to help predict which people will need to take a thyroid hormone pill after partial thyroidectomy. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/february-2026/vol-19-issue-2-p-3-4/"><strong> Read More&#8230;</strong></a></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-february-2026/">Development of a model to predict who will need to take a thyroid hormone pill after partial removal of the thyroid gland &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Long-term safety of treatment options for hyperthyroidism: which is the best? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-january-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 00:16:35 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77659</guid>

					<description><![CDATA[<p>There are 3 treatment options for hyperthyroidism – antithyroid drugs, radioactive iodine therapy and thyroid surgery. There are various factors that go into deciding which treatment option to consider, including the underlying cause for hyperthyroidism, side effects of treatment and patient preferences. This study aimed to assess the long-term safety of each of the three options of treatment for hyperthyroidism.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-january-2026/">Long-term safety of treatment options for hyperthyroidism: which is the best? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>There are 3 treatment options for hyperthyroidism – antithyroid drugs, radioactive iodine therapy and thyroid surgery. There are various factors that go into deciding which treatment option to consider, including the underlying cause for hyperthyroidism, side effects of treatment and patient preferences. This study aimed to assess the long-term safety of each of the three options of treatment for hyperthyroidism. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/january-2026/vol-19-issue-1-p-3-4/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-january-2026/">Long-term safety of treatment options for hyperthyroidism: which is the best? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Thyroid Stimulating Podcast: Iodine Deficiency and Thyroid Disorders</title>
		<link>https://www.thyroid.org/ata-medscape-collaboration-10-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 08 Dec 2025 23:03:19 +0000</pubDate>
				<category><![CDATA[Corporate News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Iodine Deficiency]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77208</guid>

					<description><![CDATA[<p>Drs. Kaniksha Desai and Elizabeth Pearce discuss iodine deficiency and thyroid disorders. This podcast is...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/ata-medscape-collaboration-10-2025/">Thyroid Stimulating Podcast: Iodine Deficiency and Thyroid Disorders</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Drs. Kaniksha Desai and Elizabeth Pearce discuss iodine deficiency and thyroid disorders. This podcast is created in partnership with the American Thyroid Association® and Medscape to discuss up-to-date diagnosis and management of a wide array of thyroid diseases. <strong><a href="https://www.medscape.com/viewarticle/1002956" target="_blank" rel="noopener noreferrer">Listen Now</a>.</strong></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/ata-medscape-collaboration-10-2025/">Thyroid Stimulating Podcast: Iodine Deficiency and Thyroid Disorders</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Thyroid®: Remote-Access Thyroidectomy and Parathyroidectomy</title>
		<link>https://www.thyroid.org/thyroid-highlighted-article-nov-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 08 Dec 2025 22:54:36 +0000</pubDate>
				<category><![CDATA[Corporate News]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Thyroid Journal]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77204</guid>

					<description><![CDATA[<p>The Official Journal of: American Thyroid Association® Remote-Access Thyroidectomy and Parathyroidectomy: A 2025 Consensus Statement...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/thyroid-highlighted-article-nov-2025/">Thyroid®: Remote-Access Thyroidectomy and Parathyroidectomy</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The Official Journal of: American Thyroid Association<sup>®</sup><strong></strong></p>
<p><a class="ga-track-click" ga-event-category="ThyroidOpenAccess" href="https://www.liebertpub.com/doi/10.1177/10507256251388410" target="_blank" rel="noopener noreferrer"><strong>Remote-Access Thyroidectomy and Parathyroidectomy: A 2025 Consensus Statement from the Asia-Pacific Society of Thyroid Surgery, American Head and Neck Society, American Association of Endocrine Surgeons, American Thyroid Association, European Society of Endocrine Surgeons, and Latin American Thyroid Society</strong></a><br />
<em>Jonathon O. Russell, Kyung Tae, Mara Y. Roth, Runhua Hou, Insoo Suh, Ralph P. Tufano, Victoria Banucchi, Emad Kandil, Raymon H. Grogan, Eren Berber, Angkoon Anuwong, Woong Youn Chung, Hoon Yub Kim, Tsung-Lin Yang, Kyu Eun Lee, Yoon Woo Koh, Marco Raffaelli, Özer Makay, Marcin Barczynski, Renan B. Lira, Alvaro Sanabria, and Luiz P. Kowalski </em><br />
<em><strong><a class="ga-track-click" ga-event-category="ThyroidOpenAccess" href="https://www.liebertpub.com/doi/10.1089/thy.2025.0360" target="_blank" rel="noopener noreferrer"></a></strong></em></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/thyroid-highlighted-article-nov-2025/">Thyroid®: Remote-Access Thyroidectomy and Parathyroidectomy</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Clinical Thyroidology®: 2025 ATA Thyroid Cancer Guidelines: Should a Lobectomy or Total Thyroidectomy Be Performed?</title>
		<link>https://www.thyroid.org/clinical-thyroidology-highlighted-article-nov-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 08 Dec 2025 22:44:03 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology]]></category>
		<category><![CDATA[Corporate News]]></category>
		<category><![CDATA[Featured]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77202</guid>

					<description><![CDATA[<p>2025 ATA Thyroid Cancer Guidelines: Should a Lobectomy or Total Thyroidectomy Be Performed? Lindsay E....</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-highlighted-article-nov-2025/">Clinical Thyroidology®: 2025 ATA Thyroid Cancer Guidelines: Should a Lobectomy or Total Thyroidectomy Be Performed?</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a class="ga-track-click" ga-event-category="CTOpenAccess" target="_blank" rel="noopener noreferrer" href="https://www.liebertpub.com/doi/10.1089/ct.2025%3B37.385-387"><strong>2025 ATA Thyroid Cancer Guidelines: Should a Lobectomy or Total Thyroidectomy Be Performed?</strong></a><br />
<em>Lindsay E. Kuo and Marika D. Russell</em></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-highlighted-article-nov-2025/">Clinical Thyroidology®: 2025 ATA Thyroid Cancer Guidelines: Should a Lobectomy or Total Thyroidectomy Be Performed?</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Do statins affect the onset of thyroid eye disease in patients with Graves’ disease? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-november-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Fri, 14 Nov 2025 00:13:33 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<category><![CDATA[Graves' Disease]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=76991</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: Thyroid eye disease (TED) develops in 25 to 40%...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-november-2025/">Do statins affect the onset of thyroid eye disease in patients with Graves’ disease? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>Thyroid eye disease (TED) develops in 25 to 40% of patients with Graves’ disease, particularly during the first 1 to 2 years following the onset of hyperthyroidism. Statins are widely prescribed drugs that lower cholesterol that also have anti-inflammatory effects and may be able to interfere with the immune response. This study aimed to determine whether starting statins early or whether the start is delayed affects the risk of developing TED in a large nationwide group. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/november-2025/vol-18-issue-11-p-5-6/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-november-2025/">Do statins affect the onset of thyroid eye disease in patients with Graves’ disease? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
